Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
43 /100
COMPONENT-LIMITED
Score updated Nov 21, 2026

BRVE — Braveheart Bio, Inc. Dilution Risk Tracker

Track BRVE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — higher scores indicate higher risk of share dilution.

Not financial advice. Do your own research before making any investment decisions.

Track BRVE — Get alerts when the score changes →

As of November 21, 2026, Braveheart Bio, Inc. (BRVE) has a DilutionWatch DilutionScore of 43/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Braveheart Bio, Inc. has a market capitalization of $1.73B, 89.87M shares outstanding.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

Offering Ability
40
Cash Runway
25
Float Risk—
Warrant Exposure
40
Convertible Debt
40

Dilution Forecast

Forecast data not available for this ticker.

Market Data

Market Cap$1.73B
Shares Outstanding89.87M
FloatN/A
Cash$121.29M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore43/100DilutionWatch score record
Shares Outstanding89.87MVerified float table or market cache
Public FloatNot availableVerified float table or market cache
Market Cap$1.73BMarket data cache
Cash Runway23.5 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

BRVE SEC Filing Activity — Last 12 Months

Shares outstanding reported by BRVE on the cover page of its latest 10-K/10-Q: 89.87M as of November 06, 2026.

DilutionWatch recorded no shelf, registration or prospectus documents for BRVE in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
8-Kcurrent report (material event)3Nov 10, 2026
10-Qquarterly report2Nov 10, 2026
SC 13D/Aamended >5% holder filing1Sep 10, 2026
SC 13Gpassive >5% holder filing4Nov 16, 2026
4insider transaction5Aug 11, 2026

Institutional Holdings

Institutional data not yet available.

Short Interest

Short Interest5.15M
Days to Cover19.6
% of FloatN/A
FINRA data as of Oct 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-11-10
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual BRVE Dilution Snapshot

Braveheart Bio, Inc. (BRVE) has a DilutionScore of 43/100, rated Medium dilution risk. Score date: November 21, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

BRVE's DilutionScore is currently 43/100 (Medium risk), with 3 score changes tracked over 90 days. The score improved from 37/100 (Medium risk).

Period Score Risk Level Duration
Nov 17 – Nov 21, 202643/100MEDIUM5 days
Oct 05 – Nov 16, 202637/100MEDIUM43 days
Sep 18 – Oct 04, 202648/100MEDIUM17 days
Aug 24 – Sep 17, 202640/100MEDIUM25 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

BRVE shares outstanding have decreased 0.2% from 90.04M (Nov 2026) to 89.87M (Nov 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Nov 17, 202689.87M——
Nov 10, 202690.04M——

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track BRVE Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment BRVE files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking BRVE — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 7,727+ tracked stocks →

Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note